1800 244 735

Helpline (02) 9874 9777

The 2013 HDBuzz Prize for Young Science Writers

We’re pleased to announce the 2013 HDBuzz Prize, an opportunity for early-career Huntington’s disease researchers to get involved in communicating HD science to the global community, see their work published here and win US$500 in Amazon vouchers!

Calling all HD scientists

After the success of the inaugural HDBuzz prize last year, we’re again looking for young scientists with a gift for communicating research news clearly and imaginatively.

So we’re excited to be announcing the 2013 HDBuzz Prize for Young Science Writers.

The HDBuzz prize is open to PhD students and postdoctoral researchers with an active involvement in any aspect of Huntington’s disease research.

Entrants should write an article of strictly no more than 1200 words, suitable for publication by HDBuzz, about a recent Huntington’s disease research paper.

In addition to the article, each submission must contain:

    n

  • a headline of no more than 10 words
  • n

  • a front-page summary of no more than 50 words
  • n

  • a Tweet of no more than 115 characters including spaces
  • n

  • at least one reference to a peer-reviewed article forming the subject of the piece
  • n

Need inspiration?

Entrants are free to choose any paper or topic, but we are also happy to suggest topics. You should not write about your own work or research you’ve been directly involved in. Email [email protected] if you’d like some suggestions.

The closing date for entries is Friday 15th November at 5pm London time.

Entries should be submitted by email, in Word document format, to [email protected]

All entries must be written in English. We regret that entries in other languages will not be considered.

Prizes!

The winners will be announced in December 2013.

The winning article will be published on HDBuzz, translated into eleven languages and syndicated to dozens of HD community sites worldwide.

The winner will receive Amazon vouchers to the value of US$500 in the currency of their choice.

Up to five runners up will also have their articles published and receive US$200 in Amazon vouchers.

Public engagement is important for every scientist’s training, so apart from the cash, this would enhance the CV of any eager young HD researcher.

Tips for successful writing

    n

  1. Take a look at several HDBuzz articles before you start, to get a good feel for our tone and style.

  2. n

  3. If in doubt, simplify.

  4. n

  5. Assume that your reader is interested in HD and willing to learn, but has no formal science training.

  6. n

  7. Explain anything beyond high-school science, in bite-sized steps. Then go back and explain the high-school science.

  8. n

  9. Apply metaphor, analogy, humor and silliness generously.

  10. n

  11. Remember to explore the limitations of what you’re writing about and try to explain what needs to happen next for it to bring HD treatments closer.

  12. n

  13. Feel free to create or use simple diagrams, striking photos or cartoons to help illustrate the article. But avoid pictures that contain text, as this causes translation problems.

  14. n

The small print

The editors' decision is final and correspondence will not be entered into. By submitting an entry, you agreeing to allow editing of your article for style and content, and its publication via HDBuzz.net and release under the Creative Commons Attribution-ShareAlike 3.0 Unported License including translation and unlimited syndication. Winners agree to be named at HDBuzz.net. Entry is not available to previous prize winners or runners up, though previous entrants who did not win are most welcome to try again. All entries will be scrutinized for plagiarism and disqualified if it is found. Side effects may include uncontrollable vomiting. Elevators may go down as well as up.

Help us twist arms!

Whether you’re a Principal Investigator (that’s ‘top boffin’ in tabloid-speak) or HD family member, chances are you know a young scientist with a neat turn of phrase and a gift for communication.

If so, please put them in touch with us or send them to this article, so they can think about entering the prize.

‘Public and patient engagement’ is important for every scientist’s training, so apart from the chance of getting their hands on those delicious prizes, this is something that would enhance the CV of any eager young HD researcher.

So, eggheads – get in touch and get cracking!

Latest Research Articles

Focusing in on fibrils; scientists give us a glimpse of huntingtin protein clumps

Published date: 8 September, 2022

A group of scientists from the EPFL in Lausanne, Switzerland have published a paper in the Journal of the American Chemical Society, describing clumps made up of a fragment of the huntingtin protein. A word that’s commonly used to describe these is “aggregates.” Using very powerful microscopes, the team was able to zoom in and ... Read more

Hereditary Disease Foundation (HDF) conference 2022 – Day 4

Published date: 2 September, 2022

DNA repair and CAG repeat instability The effect of HTT lowering on CAG repeat expansions Welcome to last day of the @hdfcures conference! We’ll only be sharing a few talks from today’s sessions, which focus on DNA repair. The first is from HDBuzz’s very own Jeff Carroll! Jeff will be sharing his work on HTT ... Read more

Hereditary Disease Foundation (HDF) conference 2022 – Day 3

Published date: 1 September, 2022

Pre-clinical work moving toward trials New tools to lower HTT showing promise in animal models Welcome back! The first talk we will be tweeting about today is from Anastasia Khvorova, who will be telling us about her teams work on lowering of Huntingtin using technology called RNAi. One of the problems in studying drug delivery ... Read more

Hereditary Disease Foundation (HDF) conference 2022 – Day 2

Published date: 31 August, 2022

We’re back for day 2 at @hdfcures! This morning’s talks will be focused on clinical trial planning and therapeutic updates from clinical studies. The sheer number of talks related to human trials compared to previous years is so encouraging! Updating metrics for clinical trials A better system for disease categorization The first talk of this ... Read more

Hereditary Disease Foundation (HDF) conference 2022 – Day 1

Published date: 31 August, 2022

Hello and welcome from the HDBuzz team who are currently at the Hereditary Disease Foundation (@hdfcures) 2022 Milton Wexler Biennial Symposium in Boston! It’s the dawn of an exciting new era for HDBuzz. Due to our new partnership with @hdfcures, we are now able to live tweet many of the talks from this meeting which ... Read more

Serious side effects reported for some people treated with the huntingtin-lowering drug AMT-130, currently in clinical trials

Published date: 29 August, 2022

Last month, we relayed positive news from uniQure’s trial testing AMT-130, a gene therapy delivered via brain surgery to lower huntingtin (HTT). Data released by uniQure in June suggested AMT-130 was safe and well tolerated in the small group of people that were treated with a low dose of the drug. Now we’re back to ... Read more